SomantiX B.V. is a Dutch biotech company focusing on the identification and development of new angiogenesis inhibitors for the treatment of solid cancers through targeting of tumor blood vessels.
Somantix’ screening platform in combination with the binder generation technologies allows validation of new therapeutic targets and development of new cancer medicines.
Company Details
- Address
- Padualaan 8, Kruyt Gebouw Rm O.807,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- somantix.com
- Keywords
- Skills Unlimited BV.
- HQ
- Utrecht, Utrecht
Somantix Bv Questions
Somantix Bv's website is somantix.com
Somantix Bv's LinkedIn profile is https://nl.linkedin.com/company/somantix-bv
Somantix Bv's industry is
Biotechnology Research
Somantix Bv's top competitors are
Skills Unlimited Bv,
Aglaia Oncology Funds,
Sopachem Bv,
Sapreme Technologies Bv,
Qvq Holding Bv,
Distrilab Bv,
U-Protein Express Bv,
Elevate,
Biospx Bv,
Vagabond Itn Network.
Somantix Bv's categories are Biotechnology Research
